Literature DB >> 24478815

KU HAPLOINSUFFIENCY CAUSES A LYMPHOPROLIFERATIVE DISORDER OF IMMATURE T-CELL PRECURSORS DUE TO IKAROS MALFUNCTION.

Zahide Ozer1, Sanjive Qazi2, Rita Ishkhanian3, Paul Hasty4, Hong Ma3, Fatih M Uckun5.   

Abstract

Ikaros (IK) malfunction has been implicated in the pathogenesis of acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Therefore, a stringent regulation of IK activity is very important. Here we provide unique genetic and biochemical evidence that the Ku protein components Ku70 and Ku80 act as positive regulators of IK function via formation of IK-Ku70 and IK-Ku80 heterodimers with augmented sequence-specific DNA binding activity. siRNA-mediated depletion of Ku70 or Ku80 reduced the sequence-specific DNA binding activity of IK in EMSA as well as the RT-PCR measured IK target gene expression levels in human cells. The interaction of Ku components with IK likely contributes to the anti-leukemic effects of IK as a tumor suppressor, because Ku70 as well as Ku80 haploinsuffiency in mice caused development of a lymphoproliferative disorder (LPD) involving CD2+CD4+CD8+CD1+IL7R+ thymic T-cell precursors with functional IK deficiency.

Entities:  

Year:  2013        PMID: 24478815      PMCID: PMC3902664          DOI: 10.5376/ijmms.2013.03.0007

Source DB:  PubMed          Journal:  Int J Mol Med Sci


  17 in total

1.  Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair.

Authors:  J R Walker; R A Corpina; J Goldberg
Journal:  Nature       Date:  2001-08-09       Impact factor: 49.962

Review 2.  Ikaros, CK2 kinase, and the road to leukemia.

Authors:  Sinisa Dovat; Chunhua Song; Kimberly J Payne; Zhanjun Li
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

3.  Zinc finger structure-function in Ikaros Marvin A Payne.

Authors:  Marvin A Payne
Journal:  World J Biol Chem       Date:  2011-06-26

4.  Developmental cell death in the liver and newborn lethality of Ku86 deficient mice suppressed by antioxidant N-acetyl-cysteine.

Authors:  Ramune Reliene; Marry E P Goad; Robert H Schiestl
Journal:  DNA Repair (Amst)       Date:  2006-08-17

5.  Ikaros isoforms: The saga continues.

Authors:  Zhanjun Li; Laura A Perez-Casellas; Aleksandar Savic; Chunhua Song; Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

6.  Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells.

Authors:  Farjana Fattah; Eu Han Lee; Natalie Weisensel; Yongbao Wang; Natalie Lichter; Eric A Hendrickson
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

7.  Characterising and predicting haploinsufficiency in the human genome.

Authors:  Ni Huang; Insuk Lee; Edward M Marcotte; Matthew E Hurles
Journal:  PLoS Genet       Date:  2010-10-14       Impact factor: 5.917

8.  Serine phosphorylation by SYK is critical for nuclear localization and transcription factor function of Ikaros.

Authors:  Fatih M Uckun; Hong Ma; Jian Zhang; Zahide Ozer; Sinisa Dovat; Cheney Mao; Rita Ishkhanian; Patricia Goodman; Sanjive Qazi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

9.  Ku86 represses lethal telomere deletion events in human somatic cells.

Authors:  Yongbao Wang; Goutam Ghosh; Eric A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

10.  Regulation of thymocyte development through CD3. II. Expression of T cell receptor beta CD3 epsilon and maturation to the CD4+8+ stage are highly correlated in individual thymocytes.

Authors:  C N Levelt; R Carsetti; K Eichmann
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  1 in total

1.  Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients.

Authors:  Fatih M Uckun; Hong Ma; Rita Ishkhanian; Martha Arellano; Anoush Shahidzadeh; Amanda Termuhlen; Paul S Gaynon; Sanjive Qazi
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.